In our latest episode of What the Tech from Boast, we sat down with Arjun Puri, CEO and Co-Founder of Symbiotic AI, to discuss democratizing precision heart health, why SR&ED tax credits should be a badge of honor, and how personal tragedy sparked a mission to reduce variability in life-or-death medical decisions. 

Today, Symbiotic AI is building Revaz AI—an AI-enabled clinical decision support solution specifically focused on coronary artery disease, the leading cause of death and disease globally. Revaz helps clinicians choose between treatment options like medical therapy, stenting, or bypass surgery by generating personalized risk predictions for each pathway. 

Boast accelerates the success of innovative businesses globally with software that integrates financial, payroll, and engineering data into a single platform of R&D intelligence.

Visit Boast.ai, sign up for our Blog newsletter and follow us on LinkedIn for weekly #InnovatorsLive sessions and the latest news to fuel your growth.

Intro and Outro music provided by Dennis Ma whose mixes you can find on Soundcloud at DJ DennyDex.